Case 9: 50 yo F with Palpitations Flashcards
Assessing CV disease risk factors
- assess ASCVD risk factors (age, gender, HTN, SBP, total and HDL cholesterol, diabetes smoking status) every 4 to 6 years in adults 20 to 79 yrs old
- estimate 10 yr ASCVD risk every 4 to 6 years in adults 40 to 79 yrs old in pts without ASCVD
Pts requiring statin (4)
- Individuals with clinical ASCVD (MI or unstable angina), stroke or TIA, peripheral vascular disease
- 40 to 75 with diabetes
- > 21 + LDL 190
- 40 to 75 with ASCVD 10 yr risk > 7.5%
5 Ps that decrease likelihood of ASC
- pleuritic chest pain (more likely PNX, PE, PNA, pleurisy, pleuropericarditis)
- reproducible with palpation on exam (MSK)
- pulsating
- positional (more likely pericarditis, pleuritic, or MSK)
- stabbing PAIN
Chest pain that is precipitated by exercise…
has a positive likelihood of 4.7 for ACS (association b/w exercise and angina is well established)
Women with angina
Have an atypical presentation, can present with palpitations rather than classic chest pain that radiates to the left arm/jaw
95% of women with acute coronary syndrome report prodromal symptoms (whereas 30% report chest pain). These prodromal Sx include…
Note: these symptoms are reported less frequently by men prior to MI
fatigue dyspnea neck/jaw pain palpitations cough N/V indigestion back pain dizziness numbness
_______ _______ has been linked to increased risk of CHD and adverse cardiac events
Chronic stress
Chest discomfort/angina history (PQRST)
Provoking factors: cold, emotional stress, meals, sex
Quality: squeezing, tightness, pressure (elephant sitting on chest)
Radiation: to neck, jaw, arm, CL arm
Assoc symptoms: sweating, SOB, nausea
Valvular abnormalities associated with palpitations
- Aortic insufficiency
- Aortic stenosis
- Mitral valve prolapse
- ASD
- VSD
- HCOM
Midsystolic click with crescendo decrescendo murmur
Mitral valve prolapse (most common structural heart abnormality presenting with palpitations)
Harsh holosystolic murmur at left sternal border that increases with Valsalva
Hypertrophic obstructive cardiomyopathy that leads to atrial fibrillation causing palpitations
Harsh holosystolic murmur that radiates to carotid
Aortic stenosis –> palpitations, dizziness
Anything that predisposes to afib can precipitate palpitations. Examples include
HCOM
Mitral regurg
CHF
What can relieve palpitation symptoms before initiating drug therapy?
Attitudinal and behavioral change
DDx for palpitations in 50 year old woman (8)
- Cardiac arrhythmias (affect sleep, at work)
- Structural heart disease
- Coronary artery disease
- Vasomotor symptoms of menopause
- Anxiety/panic disorder
- Hyperthyroidism
- Anemia
- Drugs
Hyperthyroidism can cause
palpitations via sinus tachy, afib, other supraventricular tachycardias
suspect palpitations pointing to coronary artery disease if…
- duration of palpitations is > 5 min
- description of an irregular beat that pt can tap out with their fingers
- previous Hx of heart disease
vasomotor symptoms of climacteric (menopause) cause palpitations and associated with
heat tolerance and swelling during a hot flash
Drugs
- caffeine, alcohol, tobacco
- cocaine
- sympathomimetics
- vasodilators
- anticholinergic drugs
- withdrawal from beta blockers
Does a normal EKG and physical exam rule out CAD or dysrhythmia as cause of palpitations?
No!
Exercise treadmill testing will identify CAD
Loop monitoring will catch dysrhythmia
Methods to evaluate palpitations (6)
- EKG (helpful if pt is presently experiencing palps)
- Holter monitor: detect dysrhythmia (24-48 hrs)
- Loop recorders: detect dysrhythmia (over weeks)
- Echo (valvular etiologies)
- CBC (anemia)
- TSH
+/- urine drug screen
+/- stress test (can use clinical risk factors and symptoms to predict CAD instead)
USPSTF aspirin recommendations
- aspirin in men 45 to 79 (reduce risk of MI) and women in 55 to 79 (reduce risk of ischemic stroke)
- in both groups, benefits must outweigh increased threat of GI hemorrhage
European Guidelines on CV disease prevention in clinical practice aspirin recommendations
Aspirin CANNOT BE RECOMMENDED for primary prevention in individuals without overt cardiovascular or cerebrovascular disease due to increased risk of major bleeding